Tumor Treatment Drug Market - Global Outlook and Forecast 2022-2028

March 2022 | 116 pages | ID: T20FF09FCB29EN
Market Monitor Global

Abstracts

Tumor is the name given to a group of related diseases characterized by the uncontrolled and excessive growth of abnormal cells. More than 200 different types of cancer have been identified.

This report contains market size and forecasts of Tumor Treatment Drug in Global, including the following market information:

Global Tumor Treatment Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Tumor Treatment Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Chemotherapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Tumor Treatment Drug include Roche, Celgene, Novartis, Bristol-Myers Squibb, Johnson & Johnson, Merck & Co., AstraZeneca, Pfizer and Amgen, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Tumor Treatment Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Tumor Treatment Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Tumor Treatment Drug Market Segment Percentages, by Type, 2021 (%)

• Chemotherapy
• Targeted Therapy
• Immunotherapy (Biologic Therapy)
• Hormonal Therapy
• Others

Global Tumor Treatment Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Tumor Treatment Drug Market Segment Percentages, by Application, 2021 (%)

• Blood Cancer
• Breast Cancer
• Gastrointestinal Cancer
• Prostate Cancer
• Respiratory/Lung Cancer
• Others

Global Tumor Treatment Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Tumor Treatment Drug Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Tumor Treatment Drug revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Tumor Treatment Drug revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Roche
• Celgene
• Novartis
• Bristol-Myers Squibb
• Johnson & Johnson
• Merck & Co.
• AstraZeneca
• Pfizer
• Amgen
• Eli Lilly
• AbbVie
• Takeda
• Astellas
• Ipsen
• Sanofi
• Bayer
• Biogen Idec
• Teva
• Otsuka
• Eisai
• Merck KGaA
• Gilead Sciences

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Tumor Treatment Drug Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Tumor Treatment Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL TUMOR TREATMENT DRUG OVERALL MARKET SIZE

2.1 Global Tumor Treatment Drug Market Size: 2021 VS 2028
2.2 Global Tumor Treatment Drug Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Tumor Treatment Drug Players in Global Market
3.2 Top Global Tumor Treatment Drug Companies Ranked by Revenue
3.3 Global Tumor Treatment Drug Revenue by Companies
3.4 Top 3 and Top 5 Tumor Treatment Drug Companies in Global Market, by Revenue in 2021
3.5 Global Companies Tumor Treatment Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Tumor Treatment Drug Players in Global Market
  3.6.1 List of Global Tier 1 Tumor Treatment Drug Companies
  3.6.2 List of Global Tier 2 and Tier 3 Tumor Treatment Drug Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Tumor Treatment Drug Market Size Markets, 2021 & 2028
  4.1.2 Chemotherapy
  4.1.3 Targeted Therapy
  4.1.4 Immunotherapy (Biologic Therapy)
  4.1.5 Hormonal Therapy
  4.1.6 Others
4.2 By Type - Global Tumor Treatment Drug Revenue & Forecasts
  4.2.1 By Type - Global Tumor Treatment Drug Revenue, 2017-2022
  4.2.2 By Type - Global Tumor Treatment Drug Revenue, 2023-2028
  4.2.3 By Type - Global Tumor Treatment Drug Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Tumor Treatment Drug Market Size, 2021 & 2028
  5.1.2 Blood Cancer
  5.1.3 Breast Cancer
  5.1.4 Gastrointestinal Cancer
  5.1.5 Prostate Cancer
  5.1.6 Respiratory/Lung Cancer
  5.1.7 Others
5.2 By Application - Global Tumor Treatment Drug Revenue & Forecasts
  5.2.1 By Application - Global Tumor Treatment Drug Revenue, 2017-2022
  5.2.2 By Application - Global Tumor Treatment Drug Revenue, 2023-2028
  5.2.3 By Application - Global Tumor Treatment Drug Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Tumor Treatment Drug Market Size, 2021 & 2028
6.2 By Region - Global Tumor Treatment Drug Revenue & Forecasts
  6.2.1 By Region - Global Tumor Treatment Drug Revenue, 2017-2022
  6.2.2 By Region - Global Tumor Treatment Drug Revenue, 2023-2028
  6.2.3 By Region - Global Tumor Treatment Drug Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Tumor Treatment Drug Revenue, 2017-2028
  6.3.2 US Tumor Treatment Drug Market Size, 2017-2028
  6.3.3 Canada Tumor Treatment Drug Market Size, 2017-2028
  6.3.4 Mexico Tumor Treatment Drug Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Tumor Treatment Drug Revenue, 2017-2028
  6.4.2 Germany Tumor Treatment Drug Market Size, 2017-2028
  6.4.3 France Tumor Treatment Drug Market Size, 2017-2028
  6.4.4 U.K. Tumor Treatment Drug Market Size, 2017-2028
  6.4.5 Italy Tumor Treatment Drug Market Size, 2017-2028
  6.4.6 Russia Tumor Treatment Drug Market Size, 2017-2028
  6.4.7 Nordic Countries Tumor Treatment Drug Market Size, 2017-2028
  6.4.8 Benelux Tumor Treatment Drug Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Tumor Treatment Drug Revenue, 2017-2028
  6.5.2 China Tumor Treatment Drug Market Size, 2017-2028
  6.5.3 Japan Tumor Treatment Drug Market Size, 2017-2028
  6.5.4 South Korea Tumor Treatment Drug Market Size, 2017-2028
  6.5.5 Southeast Asia Tumor Treatment Drug Market Size, 2017-2028
  6.5.6 India Tumor Treatment Drug Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Tumor Treatment Drug Revenue, 2017-2028
  6.6.2 Brazil Tumor Treatment Drug Market Size, 2017-2028
  6.6.3 Argentina Tumor Treatment Drug Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Tumor Treatment Drug Revenue, 2017-2028
  6.7.2 Turkey Tumor Treatment Drug Market Size, 2017-2028
  6.7.3 Israel Tumor Treatment Drug Market Size, 2017-2028
  6.7.4 Saudi Arabia Tumor Treatment Drug Market Size, 2017-2028
  6.7.5 UAE Tumor Treatment Drug Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Roche
  7.1.1 Roche Corporate Summary
  7.1.2 Roche Business Overview
  7.1.3 Roche Tumor Treatment Drug Major Product Offerings
  7.1.4 Roche Tumor Treatment Drug Revenue in Global Market (2017-2022)
  7.1.5 Roche Key News
7.2 Celgene
  7.2.1 Celgene Corporate Summary
  7.2.2 Celgene Business Overview
  7.2.3 Celgene Tumor Treatment Drug Major Product Offerings
  7.2.4 Celgene Tumor Treatment Drug Revenue in Global Market (2017-2022)
  7.2.5 Celgene Key News
7.3 Novartis
  7.3.1 Novartis Corporate Summary
  7.3.2 Novartis Business Overview
  7.3.3 Novartis Tumor Treatment Drug Major Product Offerings
  7.3.4 Novartis Tumor Treatment Drug Revenue in Global Market (2017-2022)
  7.3.5 Novartis Key News
7.4 Bristol-Myers Squibb
  7.4.1 Bristol-Myers Squibb Corporate Summary
  7.4.2 Bristol-Myers Squibb Business Overview
  7.4.3 Bristol-Myers Squibb Tumor Treatment Drug Major Product Offerings
  7.4.4 Bristol-Myers Squibb Tumor Treatment Drug Revenue in Global Market (2017-2022)
  7.4.5 Bristol-Myers Squibb Key News
7.5 Johnson & Johnson
  7.5.1 Johnson & Johnson Corporate Summary
  7.5.2 Johnson & Johnson Business Overview
  7.5.3 Johnson & Johnson Tumor Treatment Drug Major Product Offerings
  7.5.4 Johnson & Johnson Tumor Treatment Drug Revenue in Global Market (2017-2022)
  7.5.5 Johnson & Johnson Key News
7.6 Merck & Co.
  7.6.1 Merck & Co. Corporate Summary
  7.6.2 Merck & Co. Business Overview
  7.6.3 Merck & Co. Tumor Treatment Drug Major Product Offerings
  7.6.4 Merck & Co. Tumor Treatment Drug Revenue in Global Market (2017-2022)
  7.6.5 Merck & Co. Key News
7.7 AstraZeneca
  7.7.1 AstraZeneca Corporate Summary
  7.7.2 AstraZeneca Business Overview
  7.7.3 AstraZeneca Tumor Treatment Drug Major Product Offerings
  7.7.4 AstraZeneca Tumor Treatment Drug Revenue in Global Market (2017-2022)
  7.7.5 AstraZeneca Key News
7.8 Pfizer
  7.8.1 Pfizer Corporate Summary
  7.8.2 Pfizer Business Overview
  7.8.3 Pfizer Tumor Treatment Drug Major Product Offerings
  7.8.4 Pfizer Tumor Treatment Drug Revenue in Global Market (2017-2022)
  7.8.5 Pfizer Key News
7.9 Amgen
  7.9.1 Amgen Corporate Summary
  7.9.2 Amgen Business Overview
  7.9.3 Amgen Tumor Treatment Drug Major Product Offerings
  7.9.4 Amgen Tumor Treatment Drug Revenue in Global Market (2017-2022)
  7.9.5 Amgen Key News
7.10 Eli Lilly
  7.10.1 Eli Lilly Corporate Summary
  7.10.2 Eli Lilly Business Overview
  7.10.3 Eli Lilly Tumor Treatment Drug Major Product Offerings
  7.10.4 Eli Lilly Tumor Treatment Drug Revenue in Global Market (2017-2022)
  7.10.5 Eli Lilly Key News
7.11 AbbVie
  7.11.1 AbbVie Corporate Summary
  7.11.2 AbbVie Business Overview
  7.11.3 AbbVie Tumor Treatment Drug Major Product Offerings
  7.11.4 AbbVie Tumor Treatment Drug Revenue in Global Market (2017-2022)
  7.11.5 AbbVie Key News
7.12 Takeda
  7.12.1 Takeda Corporate Summary
  7.12.2 Takeda Business Overview
  7.12.3 Takeda Tumor Treatment Drug Major Product Offerings
  7.12.4 Takeda Tumor Treatment Drug Revenue in Global Market (2017-2022)
  7.12.5 Takeda Key News
7.13 Astellas
  7.13.1 Astellas Corporate Summary
  7.13.2 Astellas Business Overview
  7.13.3 Astellas Tumor Treatment Drug Major Product Offerings
  7.13.4 Astellas Tumor Treatment Drug Revenue in Global Market (2017-2022)
  7.13.5 Astellas Key News
7.14 Ipsen
  7.14.1 Ipsen Corporate Summary
  7.14.2 Ipsen Business Overview
  7.14.3 Ipsen Tumor Treatment Drug Major Product Offerings
  7.14.4 Ipsen Tumor Treatment Drug Revenue in Global Market (2017-2022)
  7.14.5 Ipsen Key News
7.15 Sanofi
  7.15.1 Sanofi Corporate Summary
  7.15.2 Sanofi Business Overview
  7.15.3 Sanofi Tumor Treatment Drug Major Product Offerings
  7.15.4 Sanofi Tumor Treatment Drug Revenue in Global Market (2017-2022)
  7.15.5 Sanofi Key News
7.16 Bayer
  7.16.1 Bayer Corporate Summary
  7.16.2 Bayer Business Overview
  7.16.3 Bayer Tumor Treatment Drug Major Product Offerings
  7.16.4 Bayer Tumor Treatment Drug Revenue in Global Market (2017-2022)
  7.16.5 Bayer Key News
7.17 Biogen Idec
  7.17.1 Biogen Idec Corporate Summary
  7.17.2 Biogen Idec Business Overview
  7.17.3 Biogen Idec Tumor Treatment Drug Major Product Offerings
  7.17.4 Biogen Idec Tumor Treatment Drug Revenue in Global Market (2017-2022)
  7.17.5 Biogen Idec Key News
7.18 Teva
  7.18.1 Teva Corporate Summary
  7.18.2 Teva Business Overview
  7.18.3 Teva Tumor Treatment Drug Major Product Offerings
  7.18.4 Teva Tumor Treatment Drug Revenue in Global Market (2017-2022)
  7.18.5 Teva Key News
7.19 Otsuka
  7.19.1 Otsuka Corporate Summary
  7.19.2 Otsuka Business Overview
  7.19.3 Otsuka Tumor Treatment Drug Major Product Offerings
  7.19.4 Otsuka Tumor Treatment Drug Revenue in Global Market (2017-2022)
  7.19.5 Otsuka Key News
7.20 Eisai
  7.20.1 Eisai Corporate Summary
  7.20.2 Eisai Business Overview
  7.20.3 Eisai Tumor Treatment Drug Major Product Offerings
  7.20.4 Eisai Tumor Treatment Drug Revenue in Global Market (2017-2022)
  7.20.5 Eisai Key News
7.21 Merck KGaA
  7.21.1 Merck KGaA Corporate Summary
  7.21.2 Merck KGaA Business Overview
  7.21.3 Merck KGaA Tumor Treatment Drug Major Product Offerings
  7.21.4 Merck KGaA Tumor Treatment Drug Revenue in Global Market (2017-2022)
  7.21.5 Merck KGaA Key News
7.22 Gilead Sciences
  7.22.1 Gilead Sciences Corporate Summary
  7.22.2 Gilead Sciences Business Overview
  7.22.3 Gilead Sciences Tumor Treatment Drug Major Product Offerings
  7.22.4 Gilead Sciences Tumor Treatment Drug Revenue in Global Market (2017-2022)
  7.22.5 Gilead Sciences Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Tumor Treatment Drug Market Opportunities & Trends in Global Market
Table 2. Tumor Treatment Drug Market Drivers in Global Market
Table 3. Tumor Treatment Drug Market Restraints in Global Market
Table 4. Key Players of Tumor Treatment Drug in Global Market
Table 5. Top Tumor Treatment Drug Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Tumor Treatment Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Tumor Treatment Drug Revenue Share by Companies, 2017-2022
Table 8. Global Companies Tumor Treatment Drug Product Type
Table 9. List of Global Tier 1 Tumor Treatment Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Tumor Treatment Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Tumor Treatment Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Tumor Treatment Drug Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Tumor Treatment Drug Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Tumor Treatment Drug Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Tumor Treatment Drug Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Tumor Treatment Drug Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Tumor Treatment Drug Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Tumor Treatment Drug Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Tumor Treatment Drug Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Tumor Treatment Drug Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Tumor Treatment Drug Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Tumor Treatment Drug Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Tumor Treatment Drug Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Tumor Treatment Drug Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Tumor Treatment Drug Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Tumor Treatment Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Tumor Treatment Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Tumor Treatment Drug Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Tumor Treatment Drug Revenue, (US$, Mn), 2023-2028
Table 30. Roche Corporate Summary
Table 31. Roche Tumor Treatment Drug Product Offerings
Table 32. Roche Tumor Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 33. Celgene Corporate Summary
Table 34. Celgene Tumor Treatment Drug Product Offerings
Table 35. Celgene Tumor Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 36. Novartis Corporate Summary
Table 37. Novartis Tumor Treatment Drug Product Offerings
Table 38. Novartis Tumor Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 39. Bristol-Myers Squibb Corporate Summary
Table 40. Bristol-Myers Squibb Tumor Treatment Drug Product Offerings
Table 41. Bristol-Myers Squibb Tumor Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 42. Johnson & Johnson Corporate Summary
Table 43. Johnson & Johnson Tumor Treatment Drug Product Offerings
Table 44. Johnson & Johnson Tumor Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 45. Merck & Co. Corporate Summary
Table 46. Merck & Co. Tumor Treatment Drug Product Offerings
Table 47. Merck & Co. Tumor Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 48. AstraZeneca Corporate Summary
Table 49. AstraZeneca Tumor Treatment Drug Product Offerings
Table 50. AstraZeneca Tumor Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 51. Pfizer Corporate Summary
Table 52. Pfizer Tumor Treatment Drug Product Offerings
Table 53. Pfizer Tumor Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 54. Amgen Corporate Summary
Table 55. Amgen Tumor Treatment Drug Product Offerings
Table 56. Amgen Tumor Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 57. Eli Lilly Corporate Summary
Table 58. Eli Lilly Tumor Treatment Drug Product Offerings
Table 59. Eli Lilly Tumor Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 60. AbbVie Corporate Summary
Table 61. AbbVie Tumor Treatment Drug Product Offerings
Table 62. AbbVie Tumor Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 63. Takeda Corporate Summary
Table 64. Takeda Tumor Treatment Drug Product Offerings
Table 65. Takeda Tumor Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 66. Astellas Corporate Summary
Table 67. Astellas Tumor Treatment Drug Product Offerings
Table 68. Astellas Tumor Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 69. Ipsen Corporate Summary
Table 70. Ipsen Tumor Treatment Drug Product Offerings
Table 71. Ipsen Tumor Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 72. Sanofi Corporate Summary
Table 73. Sanofi Tumor Treatment Drug Product Offerings
Table 74. Sanofi Tumor Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 75. Bayer Corporate Summary
Table 76. Bayer Tumor Treatment Drug Product Offerings
Table 77. Bayer Tumor Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 78. Biogen Idec Corporate Summary
Table 79. Biogen Idec Tumor Treatment Drug Product Offerings
Table 80. Biogen Idec Tumor Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 81. Teva Corporate Summary
Table 82. Teva Tumor Treatment Drug Product Offerings
Table 83. Teva Tumor Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 84. Otsuka Corporate Summary
Table 85. Otsuka Tumor Treatment Drug Product Offerings
Table 86. Otsuka Tumor Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 87. Eisai Corporate Summary
Table 88. Eisai Tumor Treatment Drug Product Offerings
Table 89. Eisai Tumor Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 90. Merck KGaA Corporate Summary
Table 91. Merck KGaA Tumor Treatment Drug Product Offerings
Table 92. Merck KGaA Tumor Treatment Drug Revenue (US$, Mn), (2017-2022)
Table 93. Gilead Sciences Corporate Summary
Table 94. Gilead Sciences Tumor Treatment Drug Product Offerings
Table 95. Gilead Sciences Tumor Treatment Drug Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Tumor Treatment Drug Segment by Type in 2021
Figure 2. Tumor Treatment Drug Segment by Application in 2021
Figure 3. Global Tumor Treatment Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Tumor Treatment Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Tumor Treatment Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Tumor Treatment Drug Revenue in 2021
Figure 8. By Type - Global Tumor Treatment Drug Revenue Market Share, 2017-2028
Figure 9. By Application - Global Tumor Treatment Drug Revenue Market Share, 2017-2028
Figure 10. By Region - Global Tumor Treatment Drug Revenue Market Share, 2017-2028
Figure 11. By Country - North America Tumor Treatment Drug Revenue Market Share, 2017-2028
Figure 12. US Tumor Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Tumor Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Tumor Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Tumor Treatment Drug Revenue Market Share, 2017-2028
Figure 16. Germany Tumor Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 17. France Tumor Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Tumor Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Tumor Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Tumor Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Tumor Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Tumor Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Tumor Treatment Drug Revenue Market Share, 2017-2028
Figure 24. China Tumor Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Tumor Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Tumor Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Tumor Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 28. India Tumor Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Tumor Treatment Drug Revenue Market Share, 2017-2028
Figure 30. Brazil Tumor Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Tumor Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Tumor Treatment Drug Revenue Market Share, 2017-2028
Figure 33. Turkey Tumor Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Tumor Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Tumor Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Tumor Treatment Drug Revenue, (US$, Mn), 2017-2028
Figure 37. Roche Tumor Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Celgene Tumor Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Novartis Tumor Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Bristol-Myers Squibb Tumor Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Johnson & Johnson Tumor Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Merck & Co. Tumor Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. AstraZeneca Tumor Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Pfizer Tumor Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Amgen Tumor Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Eli Lilly Tumor Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. AbbVie Tumor Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Takeda Tumor Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Astellas Tumor Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Ipsen Tumor Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Sanofi Tumor Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Bayer Tumor Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Biogen Idec Tumor Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Teva Tumor Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. Otsuka Tumor Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 56. Eisai Tumor Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 57. Merck KGaA Tumor Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 58. Gilead Sciences Tumor Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)